Sora Ely, MD, emphasized that national lung cancer screening rates remain below 10%, underscoring the urgent need for greater awareness and uptake.

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Froedtert surgeons used an FDA‑approved "glowing" drug to find a tiny lung tumor and spare healthy lung tissue.

A state-led AI screening drive flags hidden tumours early and sparks national scale-up talks ...

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.

Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...

Shira Kupperman Boehler is a runner with no symptoms and she doesn't smoke. Like an increasing number of women, she was shocked to learn she had lung cancer.

One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming ...

A new drug is helping surgeons see cancer that once went undetected, lighting up tumors in real time during surgery.Dr. Mallory Hunt, an assistant professor of cardiothoracic surgery ...

Tempus AI, Inc. TEM recently announced a collaboration with Median Technologies to integrate Median’s proprietary eyonis LCS solution into the Tempus Pixel platform. The integration is expected to ...